Business Description
Founded in 2001 and headquartered in Kita, Japan, Kringle Pharma Inc. is a drug development company focused on finding treatments for serious conditions that currently have few or no effective options. The company centers its work on a protein-based therapy known as HGF, which it is advancing across several target areas including spinal cord injury, kidney damage, voice impairment, and a progressive nerve disease called ALS.
